首页>投融资

BioAge

上市

BioAge Labs Inc is a biotechnology company developing drugs to treat ageing and ageing-related diseases.In April 2021, BioAge Labs had initiated a Phase II study in elderly patients with COVID-19.In December 2020, the company raised $90 million in an oversubscribed Series C financing.In January 2019, the company had raised $23 million in Series B financing

http://bioagelabs.com

470180

基本信息

公司全称

BioAge Labs Inc
类型

药物发现平台研发商
产业领域

药品研发/制造、医药研发/制造、化学药
公司人数

51~100人
地址

1445A South 50th Street RICHMOND CALIFORNIA 94804; US;
联系电话

1-510-8061445
邮箱

peng@bioagelabs.com
成立时间

2015-01-01

投融资

2024-09-26

上市

1.98亿美元

未透露
2024-02-13

D轮

1.7亿美元

Sofinnova Partners

Longitude Capital

RA Capital

鱼鹰资管

RTW Investments

SV Health Investors

奥博资本

Sands Capital

Pivotal bioVenture Partners

Osage University Partners

Lilly Ventures

Amgen Ventures

Andreessen Horowitz Bio+Health
2020-12-03

C轮

9000万美元

AME Cloud Ventures

Phi-X Capital

Pear Ventures

Kaiser Foundation Hospitals

红点投资

Caffeinated Capital

Felicis Ventures

Andreessen Horowitz

RockCreek Impact Fund
2019-01-25

B轮

2300万美元

AME Cloud Ventures

Khosla Ventures

Pear Ventures

红点投资

Caffeinated Capital

Felicis Ventures

Andreessen Horowitz
2017-07-28

A轮

1090万美元

AME Cloud Ventures

Pear Ventures

Felicis Ventures

Caffeinated Capital

Andreessen Horowitz
加载更多

BioAge

基本信息

投融资

相关投融资企业